Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based <i>FGFR3</i> Mutation Assay
Tahlita C.M. Zuiverloon(Erasmus MC), Ellen C. Zwarthoff(Erasmus MC), Chris H. Bangma(Erasmus MC), Martijn B. Busstra(Erasmus MC), Stephen S. Tjin(Erasmus MC), Egbert R. Boevé(Hôpitaux Universitaires Henri-Mondor)
Cited by 45
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381